Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as viability after 5 to 8 days by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at >10'2 CFU of inoculum by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at 10'5 CFU of inoculum by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by agar counting method
Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as minimum drug level resulting in no detectable growth at 10'6 CFU of inoculum after 56 days by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis JTC303 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis JTC303 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis UCF-4 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis UCF-4 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis UCF-5 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis UCF-5 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis UCF-7 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis UCF-7 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis B213 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis B213 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis B236 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis B236 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test
Antituberculosis activity against Mycobacterium paratuberculosis B238 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test